Brandywine Oak Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
Brandywine Oak Private Wealth's BMY Position: Q2 2026 in Review
Brandywine Oak Private Wealth reduced its Bristol-Myers Squibb (BMY) stake by 3.2% in Q2 2026, selling an estimated $13.3K and leaving 7,050 shares worth $406K. The position accounts for 0.03% of the portfolio, ranked #172.
Brandywine Oak Private Wealth first reported a position in BMY in Q4 2018 and has held it in 31 quarters since. The position peaked at $701K in Q2 2021. 889 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Brandywine Oak Private Wealth held 7,050 shares of Bristol-Myers Squibb worth $406K as of Q2 2026.
- Brandywine Oak Private Wealth sold 232 Bristol-Myers Squibb shares in Q2 2026, an estimated $13.3K.
- Bristol-Myers Squibb made up 0.03% of Brandywine Oak Private Wealth's portfolio in Q2 2026, its #172 holding.
- Brandywine Oak Private Wealth first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 31 quarters since.
- Brandywine Oak Private Wealth's Bristol-Myers Squibb position peaked at $701K in Q2 2021.
- 889 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Brandywine Oak Private Wealth's 13F filing for Q2 2026, filed 16 Jul 2026.